John E. Pak

John E. Pak is a highly experienced scientist specializing in protein sciences, current serving as a Senior Scientist and Protein Sciences Group Leader at Chan Zuckerberg Biohub since April 2018. In this role, John has developed infrastructure and led a team in the design, production, and characterization of recombinant biologics for various stakeholders addressing neurological and infectious diseases, including COVID-19, resulting in a publication in Nature. Prior to this, John worked at BioMarin Pharmaceutical Inc. as a Scientist II, focusing on structural biology and biophysical assay support for pre-clinical research, and held positions at the University of California, San Francisco as a Postdoctoral Associate and at the University of Toronto as a Graduate Student, where significant research in membrane proteins and glycoprotein characterization was conducted, leading to numerous first-authored publications. John holds a Ph.D. in Molecular Genetics from the University of Toronto, where education was achieved from 2002 to 2009, and a Bachelor's Degree in Molecular Genetics and Molecular Biology earned from 1998 to 2002.